Andrew Cittadine Net Worth & Insider Trades

Andrew Cittadine - Chief Operating Officer, Monopar Therapeutics

As of July 3, 2023

What is Andrew Cittadine's Net Worth?

The current estimated net worth of Monopar Therapeutics's Chief Operating Officer, Andrew Cittadine, is estimated to be about $14.82K . Andrew Cittadine owns about 24,238 units of Monopar Therapeutics common stock. In the last 2 years at Monopar Therapeutics, Andrew Cittadine has sold an estimated value of $16.68K worth.

What is Andrew Cittadine's Past Insider Trading?

Andrew Cittadine's largest purchase order was 16,053 units , worth over $49.66K on November 16, 2022. In total, Andrew Cittadine has made about 10 transactions over 2 years of their time at Monopar Therapeutics. Andrew Cittadine usually trades in July, with the busiest year in 2022 and 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Andrew Cittadine

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Andrew Cittadine's' Mailing Address?

  • Mailing address is C/o 1000 Skokie Blvd Suite 350 Wilmette IL 60091 IL

What are Monopar Therapeutics's Past Insider Trades?

Monopar Therapeutics's most recent insider trade came on November 16, 2022 by Andrew Cittadine who bought 16,053 units worth $49.66K . In the last 3 years, insiders at Monopar Therapeutics have sold an estimated value of $2M and bought an estimated value of $6.05M worth of shares. Insider trading is most common in January, with the busiest year in 2022. The most active traders at the company are Michael Brown, Director,  Arthur Klausner, Director,  and Christopher Starr, Director .

Monopar Therapeutics Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...